Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/18/23 17:46 | 10/16/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Akkaraju Srinivas | CA | DT | P | 15,000 | 6.85 | 0 | 2,190 | 48 | 6,789 | I | |||||||||||||||
10/18/23 17:44 | 10/16/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Samsara Biocapital Gp, LLC | CA | T | P | 15,000 | 6.85 | 0 | 2,190 | 48 | 6,789 | I | |||||||||||||||
10/16/23 17:46 | 10/12/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | P | 15,087 | 6.86 | 0 | 2,200 | 24 | 11,259 | D | |||||||||||||||
5/2/23 21:00 | 4/28/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | P | 203 | 6.43 | 0 | 32 | 0 | 9,060 | D | |||||||||||||||
1/9/23 17:22 | 1/5/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | P | 455 | 9.33 | 0 | 49 | 1 | 9,029 | D | |||||||||||||||
10/27/22 16:36 | 10/25/22 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | P | 1,047 | 8.04 | 0 | 130 | 1 | 8,980 | D | |||||||||||||||
10/7/22 16:30 | 10/3/22 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | P.m | 760 | 7.60 | 0 | 100 | 1 | 8,850 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |